Pulmonary Hypertension Association (PHA)

18 April 2015

The Pulmonary Hypertension Association (PHA) is the largest and oldest PH association in the world. PHA is a community-based nonprofit that relies on donations to fund its many programs, including the nation’s largest PH patient and caregiver support group network, lifesaving early diagnosis awareness and education programs, specialty care resources, and research to find ways to prevent and cure PH.

We are a young organization that is changing the history of an illness. From simple beginnings — four women around a kitchen table in Florida in 1991 — PHA has evolved in size and complexity. While we have grown, PHA has stayed true to our roots and the vision and ingenuity of our founders. Today we are a 501(c)(3) nonprofit organization, serving more than 16,000 members and supporters. We continue to work every day to end isolation, provide education, involve our constituents in everything we do, and find a cure for pulmonary hypertension.

Dr Saleh Aldammas
Congress Chair
aldammas@hotmail.com
Saph.pht@gmail.com

Dr Abdulla Aldalaan
Congress Co-chair
aldalaan@hotmail.com
Saph.pht@gmail.com

Dr Hussam Sakkijha
Head, Executive committee
sakkijhahussamm@gmail.com
Saph.pht@gmail.com

Dr Hazem Hassan
Organizing Manager
hazem@globalaccess-eg.com

About SAPH

The Saudi Association for Pulmonary Hypertension (SAPH) is a medical and research national group of many medical specialists, who shared a common interest in the field of pulmonary vascular disease.

The Conference

Honorary Intl Members (PVRI)

Ghazwan Butrous, MD

Dr. Butrous is a professor of cardiopulmonary sciences at the University of Kent, Canterbury, UK. His major research interest in PVD is in the field of management of pulmonary vascular diseases, pulmonary vascular disease secondary to infectious diseases, signaling mechanisms, and remodeling of pulmonary vasculature. He is the secretary general of the pulmonary vascular research institute (PVRI).

H Ardeschir Ghofrani, MD

Professor Ghofrani is a senior physician at the University of Giessen lung center. He is the head of the divisions of pulmonary hypertension and intensive internal medicine. Dr. Ghofrani has developed new treatment concepts for patients with various disorders of pulmonary circulation. In 2002, Dr. Ghofrani was the recipient of the travel award of the ATS and the Francois Brenot Prize of the European Respiratory Society.

Paul Hassoun, MD

Paul M. Hassoun, MD, chairs the Assembly on Pulmonary Circulation, which consists of basic scientists and clinicians interested in the understanding of the vascular basis of lung disease—from the level of cell and molecular biology to translational biology and clinical medicine.